Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector

American Journal of Surgery

Volumn 176, Issue 5, 1998, Pages 404-408

  Carew, John F ^a   Federoff, Howard ^b   Halterman, Marc ^b   Kraus, Dennis H ^a   Savage, Howard ^a   Sacks, Peter G ^a   Schantz, Stimson P ^a   Shah, Jatin P ^a   Fong, Yuman ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHEEK POUCH; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SYRIAN HAMSTER; TUMOR CELL LINE; VIRUS PARTICLE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CRICETINAE; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEAD AND NECK NEOPLASMS; HERPESVIRUS 1, HUMAN; HUMANS; INTERLEUKIN-2; TUMOR CELLS, CULTURED;

EID: 0032214177     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00231-1     Document Type: Conference Paper

References (10)

1. Liu T.J., Zhang W.W., Taylor D.L., et al. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 54:1994;3662-3667.
2. O'Malley B.W., Chen S.H., Schwartz M.R., Woo S.L. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res. 55:1995;1080-1085.
3. O'Malley B.W., Cope, Chen S.H., et al. Combination gene therapy for oral cancer in a murine model. Cancer Res. 56:1996;1737-1741.
4. Clayman G.L., Liu T.J., Overholt M., et al. Gene therapy for head and neck cancer comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21) . Arch Otolaryngol Head Neck Surg. 122:1996;489-493.
5. Goebel E.A., Davidson B.L., Graham S.M., et al. Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas. Ann Otol Rhinol Laryngol. 105:1996;562-567.
6. Geller A.I., Breakefield X.O. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science. 241:1988;1667-1669.
7. Tung C., Federoff H.J., Brownlee M., et al. Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer implications for autologous vaccine production . Human Gene Ther. 7:1996;2217-2224.
8. Sacks P.G., Parnes S.M., Gallick G.E., et al. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck. Cancer Res. 48:1988;2858-2866.
9. Bergold P.J., Casaccia-Bonnefil P., Xiu-Liu Z., Federoff H.J. Transynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of kainate receptor. Proc Natl Acad Sci. 90:1993;6165-6169.
10. Geschwind M., Lu B., Federoff H.J. Expression of neurotropic genes from herpes simplex virus type I vectors modifying neuronal phenotype. Flannagan T.R., Emerich D.F., Winn S.R. Providing Access to the Brain Alternative Approaches . 1994;462-482 Academic Press, New York.